Surface engineered antifouling optomagnetic SPIONs for bimodal targeted imaging of pancreatic cancer cells

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1601-1615

  Wang, Xiaohui ^a   Xing, Xiaohong ^a   Zhang, Bingbo ^a   Liu, Fengjun ^a   Cheng, Yingsheng ^b   Shi, Donglu ^a,c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c University of Cincinnati   (United States)

Author keywords

Bimodal imaging; BSA; MRI; Superparamagnetic iron oxide nanoparticles; Targeted imaging

Indexed keywords

ANTIFOULING AGENT; BIOLOGICAL MARKER; BOVINE SERUM ALBUMIN; CELL PROTEIN; CONTRAST MEDIUM; FLUORESCENT DYE; MONOCLONAL ANTIBODY; PLECTIN 1; PROTON; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BIMODAL TARGETED IMAGING; BIOCOMPATIBILITY; BIOMEDICAL ENGINEERING; CANCER CELL; CANCER DIAGNOSIS; CHEMICAL STRUCTURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; IONIC STRENGTH; MAGNETISM; MOLECULAR SIZE; PANCREAS ADENOCARCINOMA; PH; PROTEIN BINDING; REPRODUCIBILITY; STRUCTURE ANALYSIS; SURFACE PROPERTY;

BIMODAL IMAGING; BSA; MRI; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; TARGETED IMAGING;

CELL LINE, TUMOR; CONTRAST MEDIA; DEXTRANS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICROSCOPY, FLUORESCENCE; MULTIMODAL IMAGING; PANCREATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURFACE PROPERTIES;

EID: 84897082363     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S58334     Document Type: Article

References (44)

1. Schneider G, Siveke JT, Eckel F, Schmid RM. Pancreatic cancer: basic and clinical aspects. Gastroenterology. 2005;128(6):1606-1625.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
3. Foy SP, Manthe RL, Foy ST, Dimitrijevic S, Krishnamurthy N, Labhasetwar V. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. ACS Nano. 2010;4(9):5217-5224.
4. Wang QB, Han Y, Jiang TT, et al. MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide. Eur Radiol. 2011;21(5): 1016-1025.
5. Liu F, Laurent S, Fattahi H, Vander Elst L, Muller RN. Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging. Nanomedicine (Lond). 2011;6(3):519-528.
6. Cheng FY, Su CH, Yang YS, et al. Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applications. Biomaterials. 2005;26(7):729-738.
7. Thorek DL, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng. 2006;34(1):23-38.
8. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004;17(7):484-499.
9. Sun S, Zeng H, Robinson DB, et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc. 2004;126(1):273-279.
10. Yu WW, Chang E, Falkner JC, et al. Forming biocompatible and nonaggregated nanocrystals in water using amphiphilic polymers. J Am Chem Soc. 2007;129(10):2871-2879.
11. Xu C, Xu K, Gu H, et al. Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. J Am Chem Soc. 2004;126(32):9938-9939.
12. Niu D, Li Y, Qiao X, et al. A facile approach to fabricate functionalized superparamagnetic copolymer-silica nanocomposite spheres. Chem Commun (Camb). 2008;(37):4463-4465.
13. Chen H, Wang L, Yeh J, et al. Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating. Biomaterials. 2010;31(20): 5397-5407.
14. Salvador-Morales C, Zhang L, Langer R, Farokhzad OC. Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. Biomaterials. 2009;30(12):2231-2240.
15. Cho EC, Xie J, Wurm PA, Xia Y. Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett. 2009;9(3):1080-1084.
16. Kairdolf BA, Mancini MC, Smith AM, Nie S. Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatized surface coatings. Anal Chem. 2008;80(8):3029-3034.
17. Bentzen EL, Tomlinson ID, Mason J, et al. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjug Chem. 2005;16(6):1488-1494.
18. Simpson CA, Agrawal AC, Balinski A, Harkness KM, Cliffel DE. Short-chain PEG mixed monolayer protected gold clusters increase clearance and red blood cell counts. ACS Nano. 2011;5(5): 3577-3584.
19. Strable E, Bulte JWM, Moskowitz B, Vivekanandan K, Allen M, Douglas T. Synthesis and characterization of soluble iron oxide-dendrimer composites. Chem Mater. 2001;13(6):2201-2209.
20. Wakayama J, Sekiguchi H, Akanuma S, Ohtani T, Sugiyama S. Methods for reducing nonspecific interaction in antibody-antigen assay via atomic force microscopy. Anal Biochem. 2008;380(1):51-58.
21. Zhang B, Wang X, Liu F, Cheng Y, Shi D. Effective reduction of nonspecific binding by surface engineering of quantum dots with bovine serum albumin for cell-targeted imaging. Langmuir. 2012;28(48): 16605-16613.
22. Zhang B, Li Q, Yin P, et al. Ultrasound-triggered BSA/SPION hybrid nanoclusters for liver-specific magnetic resonance imaging. ACS Appli Mater Interfaces. 2012;4(12):6479-6486.
23. Remsen LG, McCormick CI, Roman-Goldstein S, et al. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. AJNR Am J Neuroradiol. 1996;17(3):411-418.
24. Huang J, Wang L, Lin R, et al. Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting. ACS Appl Mater Interfaces. 2013;5(11):4632-4639.
25. Huang J, Xie J, Chen K, et al. HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging. Chem Commun (Camb). 2010;46(36):6684-6686.
26. Lee JH, Lee K, Moon SH, Lee Y, Park TG, Cheon J. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed Engl. 2009;48(23): 4174-4179.
27. Bausch D, Thomas S, Mino-Kenudson M, et al. Plectin-1 as a novel biomarker for pancreatic cancer. Clin Cancer Res. 2011;17(2):302-309.
28. Kelly KA, Bardeesy N, Anbazhagan R, et al. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med. 2008;5(4):e85.
29. Dong A, Ye X, Chen J, et al. A generalized ligand-exchange strategy enabling sequential surface functionalization of colloidal nanocrystals. J Am Chem Soc. 2011;133(4):998-1006.
30. Yang Q, Gong X, Song T, et al. Quantum dot-based immunochromatography test strip for rapid, quantitative and sensitive detection of alpha fetoprotein. Biosens Bioelectron. 2011;30(1):145-150.
31. Mahmoudi M, Simchi A, Imani M, et al. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf B Biointerfaces. 2010;75(1):300-309.
32. Carter DC, Ho JX. Structure of serum albumin. Adv Prot Chem. 1994;45:153-203.
33. Huang X, Li BY, Zhang H, Hussain I, Liang LY, Tan BE. Facile preparation of size-controlled gold nanoparticles using versatile and end-functionalized thioether polymer ligands. Nanoscale. 2011;3(4): 1600-1607.
34. Cui Y, Gong XQ, Zhu SJ, et al. An effective modified method to prepare highly luminescent, highly stable water-soluble quantum dots and its preliminary application in immunoassay. J Mater Chem. 2012;22(2): 462-469.
35. Tang ZH, Xu B, Wu BH, Germann MW, Wang GL. Synthesis and structural determination of multidentate 2,3-dithiol-stabilized Au clusters. J Am Chem Soc. 2010;132(10):3367-3374.
36. Lutz HD, Himmrich J, Schmidt M. Lattice vibration spectra. Part LXXXVI. Infrared and Raman spectra of baryte-type TlClO4, TlBF4, and NH4BF4 single crystals and of 11B-enriched NH4BF4. J Alloys Compd. 1996;241(1-2):1-9.
37. Wright AK, Thompson MR. Hydrodynamic structure of bovine serum albumin determined by transient electric birefringence. Biophys J. 1975;15(2 Pt 1):137-141.
38. Burtea C, Laurent S, Murariu O, et al. Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovasc Res. 2008;78(1):148-157.
39. Monopoli MP, Walczyk D, Campbell A, et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc. 2011;133(8):2525-2534.
40. Amiri H, Bordonali L, Lascialfari A, et al. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. Nanoscale. 2013;5(18):8656-8665.
41. Sakai G, Nakata S, Uda T, Miura N, Yamazoe N. Highly selective and sensitive SPR immunosensor for detection of methamphetamine. Electrochim Acta. 1999;44(21-22):3849-3854.
42. Festag G, Steinbruck A, Wolff A, Csaki A, Moller R, Fritzsche W. Optimization of gold nanoparticle-based DNA detection for microarrays. J Fluoresc. 2005;15(2):161-170.
43. Mirshafiee V, Mahmoudi M, Lou KY, Cheng JJ, Kraft ML. Protein corona significantly reduces active targeting yield. Chem Commun (Camb). 2013;49(25):2557-2559.
44. Salvati A, Pitek AS, Monopoli MP, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol. 2013;8(2):137-143.